WELCOME TO JOHNS HOPKINS HEALTH ALERTS!

This free public service from Johns Hopkins Medicine helps keep you up to date on the latest breakthroughs for the most common medical conditions which prevent healthy aging. Browse all the articles via the Health Alert Topics navigation bar on the right, or read the headlines below.


Get the latest news sent straight to your Inbox. Register now for your FREE Johns Hopkins Health Alerts. Check the boxes below for all the topics you are interested in, enter your email address, and click "Send." It's fast, easy, and FREE.   Benefits of Being A Registered User

Enter your email here: (Example: yourname@domain.com)
Please send my alerts as:

We value your privacy and will never rent your email address.Already a Member? Manage your Health Alerts


Johns Hopkins Health Alert

The Gleason Behind the Gleason Score

Comments (2)

If you have had prostate cancer, you probably know that the Gleason score is the most important factor in predicting your current state of prostate cancer and its probable outcome. The score is based on tumor grade -- an indication of the tumor's aggressiveness. Tumor grade reflects how far the cancer cells deviate from normal, healthy cells, which are highly organized, with well-defined structures.

Cancer cells display various degrees of disorganization and distortion and could be likened to a Jackson Pollock painting. Cancers whose cells appear closest to normal are considered grade 1 and generally are the least aggressive; those with highly irregular, disorganized features are classified as grade 5 and generally are the most aggressive.

The Gleason score is derived by determining the two most prevalent organizational patterns in the tumor, assigning each a grade, and then adding the two numbers together. For example, if the most common pattern is grade 3 and the next most common pattern is grade 4, the Gleason score would be 3 + 4 = 7. Most pathologists do not recommend assigning Gleason scores below 5 based on needle biopsies because when the prostate is removed and the entire gland is evaluated, lower Gleason scores are almost always upgraded.

Most urologists would classify Gleason scores of 5 and 6 as low-grade tumors, a Gleason score of 7 as intermediate, and Gleason scores of 8, 9, and 10 as high grade, with the least favorable outlook.

The Gleason score was originally devised by Donald F. Gleason, M.D., a pathologist who created the unique and now ubiquitous scoring system in the 1960s based on his observations of prostate tissue taken from biopsy samples of more than 300 patients. The prostate tissue, when riddled with microscopic tumors, had a certain pattern when viewed under a microscope, and Dr. Gleason took note of that, assigning numbers to the various architectural patterns. He finally arrived at five representative pictures that were characteristic of all the patients. When reviewing background data on the patients, a strong correlation was found between their "Gleason score" and the patients' death rates.

By the late 1980s, Dr. Gleason’s system was used in all medical publications on prostate cancer, and is still in use today throughout the world. Your PSA test result, along with your Gleason score, predicts the likely outcome of prostate cancer and it's the gold standard test that will be used to diagnose more than 186,000 men this year with the disease.

Posted in Prostate Disorders on September 3, 2009
Reviewed January 2011


Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer


Notify Me

Would you like us to inform you when we post new Prostate Disorders Health Alerts?

Post a Comment

Comments

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.


Your article states that "Your PSA test result, along with your Gleason score, predicts the likely outcome of prostate cancer". However, the article also notes that "Most pathologists do not recommend assigning Gleason scores below 5 based on needle biopsies". What then is the value of the needle biopsie? Is it irrelevant? What is the best indication for performing prostatectomy?

Posted by: pinebaron | September 5, 2009 9:55 AM

Why are we even discussing the PSA any more? Over half of the "positive" results (indicating cancer) are false. And 50% of those whose PSA results are good ones DO HAVE PROSATE CANCER. Even the American Cancer Society has back off recommending this test!

And Gleason/Smeeshon. We are still only treating the symptoms, not the disease. And the needle biopsy? - Sure, lets run a needle through our rectum, and transfer fecal matter into the prostate. That should help! And don't worry about the blood in your urine, stool, or semen. That will go away in a couple of weeks! Sounds like a great diagnostic tool!

Eat right, reduce your fat intake, eliminate sugar from your diet, exercise regularly, don't smoke, drnk very little alcohol, take as many supplemewnts as you can get your hands on, and attempt to overcome 40 or 50 years of bad nutritional intake. That will help to postively deal with the cause of the disease. Letting doctors burn away or cut away your insides won't (excuse the pun) cut it!

Posted by: lmgtexas | September 8, 2009 3:56 PM

Post a Comment


Already a subscriber?

Login

Forgot your password?

New to Johns Hopkins Health Alerts?

Register to submit your comments.

(example: yourname@domain.com)

(800) 829-0422

Registered Users Log-in:

Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being a Registered User

Health Topic Pages

  • Health Alert
  • Special Report

What is this?

XML


Johns Hopkins' Bestsellers Prostate Disorders

Our Featured Titles:

Johns Hopkins Prostate Disorders White Paper

The Johns Hopkins Prostate Bulletin Cover

  • The Johns Hopkins Prostate Disorders Bulletin
    The Johns Hopkins Prostate Disorders Bulletin is a quarterly publication that presents the latest treatment information available on prostate cancer, enlarged prostate (BPH), and prostatitis to help you take charge of your medical care for prostate disease. Each issue is like having an in-depth consultation with a leading specialist. PLUS, subscribe now and get a special discount PLUS 5 FREE Special Reports as INSTANT PDF DOWNLOADS:
    • Special Report #1: BPH (Benign Prostatic Hyperplasia)
    • Special Report #2: Diet and Prostate Health
    • Special Report #3: Treating Overactive Bladder
    • Special Report #4: Chronic Prostatitis: New Research, Renewed Hope
    • Special Report #5: The Radical Prostatectomy

    Click here to read more or order The Johns Hopkins Prostate Disorders Bulletin.


    Related Titles:

    THE JOHNS HOPKINS PROSTATE LIBRARY


    A series of cutting-edge publications designed to address your specific prostate questions.

    • Choosing the Right Treatment for Prostae Cancer
      A must-read primer for any man recently diagnosed with prostate cancer who is looking for answers to pressing questions about treatment options. Our specialists explain in-depth: proactive surveillance, also known as expectant management ... nerve-sparing radical prostatectomy . . . radiation therapy, including EBRT, 3DCRT, IMRT, IGT, and brachytherapy. Written by Jacek L. Mostwin M.D. and colleagues at the world-renowned James Buchanan Brady Urological Institute at Johns Hopkins - the hospital and urology center ranked #1 year after year by U.S. News & World Report -- Choosing the Right Treatment for Prostate Cancer takes you step-by-step through the decision-making process to help you make informed choices.
      Read More

    Restoring Sexual Intimacy After Prostate Cancer Treatment

    The Best Treatment Strategies for BPH

    • The Best Treatment Strategies for BPH
      Written by a team of top specialists at Johns Hopkins' renowned Brady Urological Institute, this essential guide presents the latest thinking on managing benign prostatic hyperplasia (BPH) or enlarged prostate. The report answers dozens of questions from patients searching for practical, no-nonsense advice on living with BPH. It provides a thorough discussion of your surgical options when medication no longer works, weighing the pros and cons of TUNA, TUMT, and TURP. Armed with the information in this guide, you'll be able to meet with your own physician and make the right decisions in your quest for the best possible outcome.
      Read more...

    The Latest Treatments for Advanced Prostate Cancer

    • The Latest Treatments for Advanced Prostate Cancer
      If you've just received the bad news that your prostate cancer has returned, America's #1 Urology Center's specialists offer this up-to-the-minute treatment guide is designed as a detailed primer on advanced prostate cancer, so you can know all your options for dealing with this major health
      Read more...